Uric acid and hypertension

Michael Schachter1

  • 1Department of Clinical Pharmacology, National Heart and Lung Institute, Imperial College School of Medicine, St Mary's Hospital, London, UK. M.Schachter@imperial.ac.uk

Insights

High uric acid levels link to cardiovascular disease and metabolic syndrome, potentially predicting outcomes. Further research is needed to confirm if lowering uric acid benefits hypertension management.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Elevated uric acid is linked to cardiovascular disease and metabolic syndrome.
  • Hyperuricemia may predict clinical outcomes and hypertension onset.
  • Uric acid's role as an independent risk factor requires further clarification due to its association with other factors.

Purpose of the Study:

  • To explore the association between uric acid levels and cardiovascular disease and metabolic syndrome.
  • To investigate the potential role of uric acid in the pathogenesis of hypertension.
  • To examine the therapeutic implications of targeting uric acid in cardiovascular and hypertensive conditions.

Main Methods:

  • Review of existing literature on uric acid, cardiovascular disease, metabolic syndrome, and hypertension.
  • Analysis of pathophysiological mechanisms linking uric acid to renal and vascular damage.
  • Exploration of data regarding the impact of lowering uric acid on blood pressure.

Main Results:

  • Increased uric acid is associated with cardiovascular disease, metabolic syndrome, and hypertension.
  • Uric acid may contribute to renal and vascular damage, including endothelial dysfunction.
  • Limited evidence suggests lowering uric acid might reduce blood pressure in some cases.

Conclusions:

  • The precise role of uric acid as an independent risk factor for cardiovascular disease and hypertension remains under investigation.
  • The relationship between elevated uric acid and triglyceride levels in metabolic syndrome needs further definition.
  • Further research is required to determine if uric acid should be a therapeutic target and to establish optimal methods for lowering serum urate levels.

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...